Patent US4569675A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4569675A Expired / Lapsed US ⏱️ 0.0 years remaining

Transcutaneous infusion system

Assignee: NATIONSCREDIT COMMERCIAL Corp
•
Filing: 1983-09-12
•
Granted: 1986-02-11
•
Expires: 2003-09-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A transcutaneous infusion system comprises an implantable infusate injection port for conducting infusate from the port to an infusion site in the body. The port is supplied with infusate through a penetrable septum located directly under the skin. To infuse the patient, a flexible injection cannula encircling a needle which is slightly longer than the cannula is inserted through the septum into the port and then the needle is withdrawn leaving the free end of the flexible cannula in the port. The opposite end of the cannula is provided with a fitting for connecting the cannula to the outlet of a fluid administration set. The system also includes a bracket removably connected to the cannula and taped to the patient adjacent the injection site so that the bracket anchors the cannula and its associated fittings and tubing against the patient's skin, while assuring that the cannula is not bent to an extent that will stop fluid flow into the port.

Inventors

  • 👤 Frank R. Prosl
  • 👤 Joseph J. Szymanski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:53
CPC Classifications
A; A61; A61M; A61M39/00; A61M39/02; A61M39/0208; A61M5/00; A61M5/14; A61M5/158; A61M2005/1581; A61M2039/0036; A61M2039/0081; Y; Y10; Y10S; Y10S128/00; Y10S128/26

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 214 words
A transcutaneous infusion system comprising A. an implantable infusate injection port including a housing and having a self-sealing injection septum leading into the port and an outlet tube leading from the port, said injection port being arranged to be implanted in a human or animal body with the septum located directly under the skin and the outlet tube leading to an infusion site in the body; B. an injection set including a flexible injection cannula and a fitting at one end of the cannula, the opposite end of the cannula being insertable through said septum into the port; and C. a cannula retaining bracket having opposite end segments which are generally perpendicular to one another and an intermediate segment which makes a curved transition between said two end segments, all of said segments lying in a common first plane, and tab means integral with said retaining means and extending in a second plane perpendicular to said first plane and having a flat undersurface so that, when the bracket is positioned with its tab means undersurface flush against the skin surface with said one end segment located adjacent to the injection site, the bracket retains said cannula in a gentle more or less right-angle bend with the cannula fitting held close to the skin surface.
Claim 2
Dependent Claim 214 words
A transcutaneous infusion system comprising A. an implantable infusate injection port including a housing and having a self-sealing injection septum leading into the port and an outlet tube leading from the port, said injection port being arranged to be implanted in a human or animal body with the septum located directly under the skin and the outlet tube leading to an infusion site in the body; B. an injection set including a flexible injection cannula and a fitting at one end of the cannula, the opposite end of the cannula being insertable through said septum into the port; and C. a cannula retaining bracket having opposite end segments which are generally perpendicular to one another and an intermediate segment which makes a curved transition between said two end segments, all of said segments lying in a common first plane, and tab means integral with said retaining means and extending in a second plane perpendicular to said first plane and having a flat undersurface so that, when the bracket is positioned with its tab means undersurface flush against the skin surface with said one end segment located adjacent to the injection site, the bracket retains said cannula in a gentle more or less right-angle bend with the cannula fitting held close to the skin surface.
Claim 3
Dependent Claim 20 words
The infusion system defined in claim 1 and further including means for adhering the tab means to the skin surface.
Claim 4
Dependent Claim 74 words
The system defined in claim 1 wherein said injection port also includes A. a tubular sealing member including a stem whose diameter is selected to engage snugly in the end of said outlet tube; and B. means for releasably connecting said sealing member to said housing in fluid connection with said port so that different diameter outlet tubes may be connected selectively to the port by appropriate selection of the sealing member stem diameter.

References Cited (Backward Citations)

US3310051A Cited
US3714945A Cited
US4400169A Cited
US4397641A Cited
US4419094A Cited
US4435174A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-02-10 1989-08-12 1990-02-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-02-10 1993-08-12 1994-02-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-02-10 1997-08-12 1998-02-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag